1HANDSCHUMACHER R E, HARDING M W, RICE J, et al. Cyclophilin: a specific cytosolic binding protein for cyclosporin A[J]. Science, 1984, 226(4674): 544-547.
2WANG P, HEITMAN J. The cyclophilins [J]. Genome Biol, 2005, 6(7): 226.
3THIRIAULT Y, LOGAN T M, MEADOWS R, et al. Solution structure of the cyclosporin A/cyclophilin complex by NMR [J]. Nature, 1993, 361(6407): 88-91.
4SMART E J, YING Y, DONZELL W C, et al. A role for caveolin in transport of cholesterol from endoplasmic reticulumto plasma membrane[J]. J Biol Chem, 1996, 271(46) : 29427- 29435.
5SATOH K, SHIMOKAWA H, BERK B C. Cyclophilin A: promising new target in cardiovascular therapy[J]. Circ J, 2010, 74( 11 ) : 2249-2256.
6DAMSKER J M, BUKRINSKY M I, CONSTANT S L. Preferential chemotaxis of activated human CD4 + T cells by extracellular cyclophilin A [ J ]. J Lenkoc Biol, 2007, 82 (3) : 613-618.
7SONG F, ZHANG X, REN X B, et al. Cyclophilin A (CyPA) induces chemutaxis independent of its peptidylprolyl cis-trans isomerase activity: direct binding between CyPA and the ectodomain of CDlg7 [J]. J Biol Chem, 2011, 286 (10): 8197- 8203.
8SCHLEGEL J, REDZIC J S, PORTER C C, et al. Solution characterization of the extracellular region of CD147 and its interaction with its enzyme ligand eyclophilin A [J]. J Mol Biol, 2009, 391(3): 518-535.
9AKKI A, ZHANG M, MURDOCH C, et al. NADPH oxidase signaling and cardiac myocyte function [J ]. J Mol Cell Cardiol, 2009. 47(1)._ 15-22.
10SATOH K, NIGRO P, ZEIDAN A, et al. Cyclophilin A promotes cardiac hypertrophy in apolipoprotein E-deficient mice [J]. Arterioscler Thromb Vasc Biol, 2011, 31 (5) : 1116- 1123.
7Tian-Tian Z, Jun-Feng Z, Heng G. Functions of cyclophilin A in atherosclerosis [ J ]. Exp Clin Cardiol, 2013,18 ( 2 ) : 118-124.
8Boos C J, Lip GY. Is hypertension an inflammatory process [ J]. Curt Pharm Des, 2006,12 ( 13 ) : 1623-1635.
9Cusack MR, Marber MS, Lambiase PD, et al. Systemic inflamma- tion in unstable angina is the result of myocardial necrosis [ J ]. J Am Coll Cardio1,2002 ,39 ( 12 ) : 1917-1923.
10Gerstein H. G|ycosylated hemoglobin :finally ready of prime time as cardiovascular risk facter [ J ]. Anuintern Med, 2004, 141 : 475- 476.
